Ivana Kacířová

822 total citations
69 papers, 630 citations indexed

About

Ivana Kacířová is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Ivana Kacířová has authored 69 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pediatrics, Perinatology and Child Health, 22 papers in Psychiatry and Mental health and 19 papers in Pharmacology. Recurrent topics in Ivana Kacířová's work include Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers) and Antibiotics Pharmacokinetics and Efficacy (14 papers). Ivana Kacířová is often cited by papers focused on Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers) and Antibiotics Pharmacokinetics and Efficacy (14 papers). Ivana Kacířová collaborates with scholars based in Czechia and Germany. Ivana Kacířová's co-authors include Milan Grundmann, Hana Brozmanová, Naděžda Petejová, Arnošt Martínek, Karel Lemr, Karel Urbánek, Zdeněk Švagera, Josef Zadražil, David Stejskal and Marcela Káňová and has published in prestigious journals such as International Journal of Molecular Sciences, Medicine and Clinica Chimica Acta.

In The Last Decade

Ivana Kacířová

62 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivana Kacířová Czechia 13 185 167 162 101 97 69 630
Milan Grundmann Czechia 16 230 1.2× 266 1.6× 176 1.1× 150 1.5× 84 0.9× 89 726
Hana Brozmanová Czechia 15 168 0.9× 247 1.5× 149 0.9× 148 1.5× 73 0.8× 65 645
Dobrin Svinarov Bulgaria 15 62 0.3× 151 0.9× 117 0.7× 107 1.1× 153 1.6× 53 686
Pietro Fagiolino Uruguay 15 232 1.3× 284 1.7× 92 0.6× 36 0.4× 104 1.1× 73 733
Nicolas Ansermot Switzerland 19 207 1.1× 215 1.3× 200 1.2× 73 0.7× 162 1.7× 41 1.0k
Kuntheavy Ing Lorenzini Switzerland 13 80 0.4× 116 0.7× 194 1.2× 35 0.3× 83 0.9× 40 832
EJ Begg New Zealand 13 76 0.4× 214 1.3× 283 1.7× 117 1.2× 128 1.3× 19 851
Olivier Tribut France 19 114 0.6× 138 0.8× 296 1.8× 69 0.7× 184 1.9× 48 1.4k
Sherif Hanafy Mahmoud Canada 13 145 0.8× 122 0.7× 176 1.1× 15 0.1× 43 0.4× 46 548
Anup Majumdar United States 20 84 0.5× 147 0.9× 388 2.4× 33 0.3× 110 1.1× 49 1.3k

Countries citing papers authored by Ivana Kacířová

Since Specialization
Citations

This map shows the geographic impact of Ivana Kacířová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Kacířová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Kacířová more than expected).

Fields of papers citing papers by Ivana Kacířová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivana Kacířová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Kacířová. The network helps show where Ivana Kacířová may publish in the future.

Co-authorship network of co-authors of Ivana Kacířová

This figure shows the co-authorship network connecting the top 25 collaborators of Ivana Kacířová. A scholar is included among the top collaborators of Ivana Kacířová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana Kacířová. Ivana Kacířová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kacířová, Ivana, et al.. (2024). Whole blood concentrations of fingolimod and its pharmacologically active metabolite fingolimod phosphate obtained during routine health care of patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 93. 106246–106246. 1 indexed citations
4.
5.
6.
Kacířová, Ivana, et al.. (2024). Analysis of Concentrations of Monomethyl Fumarate in Patients with Multiple Sclerosis: Result from Routine Health Care. CNS & Neurological Disorders - Drug Targets. 23(12). 1516–1523. 2 indexed citations
7.
Brozmanová, Hana, et al.. (2021). Therapeutic Drug Monitoring Guided Fluconazole Therapy in a Patient with Cholangitis Sepsis. Personalized Medicine. 19(1). 9–14. 2 indexed citations
8.
Grundmann, Milan, et al.. (2021). Was it necessary to change the therapeutic range of topiramate?. British Journal of Clinical Pharmacology. 88(2). 613–618. 2 indexed citations
9.
10.
11.
Petejová, Naděžda, Arnošt Martínek, Josef Zadražil, et al.. (2020). Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents—Pathophysiology and Biomarkers—A Review. International Journal of Molecular Sciences. 21(19). 7115–7115. 58 indexed citations
12.
Kacířová, Ivana, et al.. (2020). Meropenem serum concentrations in intensive care patients: a retrospective analysis. Česká a slovenská farmacie. 69(5-6). 230–236. 3 indexed citations
13.
Káňová, Marcela, et al.. (2018). Amiodarone induced acute hepatotoxicity during intravenous application. 32(3). 34–37.
14.
Kacířová, Ivana & Milan Grundmann. (2016). Therapeutic monitoring of antiepileptic drugs, part II - "new" antiepileptics, special groups of patients. 30(2). 16–22. 4 indexed citations
15.
Kacířová, Ivana & Milan Grundmann. (2016). Analýza vývoje používání antiepileptik u těhotných žen s epilepsií v Moravskoslezském kraji. 30(2). 23–28. 4 indexed citations
16.
Kacířová, Ivana, et al.. (2016). Therapeutic drug monitoring in psychiatry - possibilities and use in practice. 17(1). 10–14. 2 indexed citations
17.
Grundmann, Milan & Ivana Kacířová. (2016). Therapeutic monitoring of antiepileptic drugs, part I - general principles, "old" antiepileptics. 30(2). 9–15. 5 indexed citations
18.
Grundmann, Milan, et al.. (2012). Intoxikace venlafaxinem - využití TDM, fenotypizace a genotypizace. 26(2). 90–92. 1 indexed citations
19.
Kacířová, Ivana, et al.. (2012). Obecné zásady terapeutického monitorování hladin psychofarmak. 26(3). 131–134. 1 indexed citations
20.
Petejová, Naděžda, et al.. (2011). Dávkování vankomycinu při kontinuální náhradě funkce ledvin. 25(3). 116–121. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milan Grundmann Breakdown of academic impact, for papers by Hana Brozmanová Breakdown of academic impact, for papers by Dobrin Svinarov Breakdown of academic impact, for papers by Pietro Fagiolino Breakdown of academic impact, for papers by Nicolas Ansermot Breakdown of academic impact, for papers by Kuntheavy Ing Lorenzini Breakdown of academic impact, for papers by EJ Begg Breakdown of academic impact, for papers by Olivier Tribut Breakdown of academic impact, for papers by Sherif Hanafy Mahmoud Breakdown of academic impact, for papers by Anup Majumdar
Rankless by CCL
2026